Monday's healthcare upgrades, downgrades, and initiations

Jazz Pharmaceuticals (JAZZ -2%) cut to Neutral from Buy at Goldman. Price target is $123.

Aveo Pharmaceuticals (AVEO -3.5%) cut to Underperform from Sector Perform at RBC. Price target is $2.

Centene (CNC +1.5%) upgraded to Positive from Neutral at Susquehanna. Price target is $68.

St. Jude Medical (STJ +2.4%) upgraded to Outperform from Market Perform at BMO. Price target is $66.

Evogene (EVGN -3.4%) initiated at Outperform at Oppenheimer. Price target is $26.

Impax Labs (IPXL +0.9%started at Buy at Goldman. Price target is $29.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs